Debilitating musculoskeletal pain and stiffness with letrozole and exemestane: Associated tenosynovial changes on magnetic resonance imaging

Breast Cancer Research and Treatment

Volumn 104, Issue 1, 2007, Pages 87-91

  Morales, Leilani ^a   Pans, Steven ^a   Paridaens, Robert ^a   Westhovens, Rene ^a   Timmerman, Dirk ^a   Verhaeghe, Johan ^a   Wildiers, Hans ^a   Leunen, Karin ^a   Amant, Frederic ^a   Berteloot, Patrick ^a   Smeets, Ann ^a   Van Limbergen, Erik ^a   Weltens, Caroline ^a   Van Den Bogaert, Walter ^a   De Smet, Luc ^a   Vergote, Ignace ^a   Christiaens, Marie Rose ^a   Neven, Patrick ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Aromatase inhibitors; Arthralgia; Exemestane; Letrozole; Magnetic resonance imaging; Musculoskeletal pain; Myalgia; Ultrasound

Indexed keywords

EXEMESTANE; LETROZOLE;

ADULT; AGED; ARTHRALGIA; ARTICLE; BIOCHEMISTRY; BREAST CANCER; CLINICAL ARTICLE; CORRELATION ANALYSIS; FEMALE; HAND JOINT; HUMAN; MUSCULOSKELETAL PAIN; MUSCULOSKELETAL STIFFNESS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PATIENT COMPLIANCE; POSTMENOPAUSE; PRIORITY JOURNAL; RHEUMATOLOGY; SYNOVIUM; ULTRASOUND; WRIST;

AGED; ANDROSTADIENES; AROMATASE INHIBITORS; BREAST NEOPLASMS; CARPAL TUNNEL SYNDROME; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; MUSCULOSKELETAL DISEASES; NITRILES; PAIN; SEVERITY OF ILLNESS INDEX; TRIAZOLES; WRIST JOINT;

EID: 34250866267     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-006-9394-6     Document Type: Article

References (17)

1. The ATAC Trialists' Group (2005) Results of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer. Lancet 365:60-62
2. Goss P, Ingle J, Martino S et al (2003) A randomized trial of letrozole in postmenopausal women after 5 years of tamoxifen therapy for early-stage breast cancer. N Engl J Med 349:1-10
3. Coombes RC, Hall E, Gibson LJ et al (2004) A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer. N Engl J Med 350:1081-1092
4. The Breast International Group (BIG) 1-98 Collaborative Group (2005) A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer. N Engl J Med 353:2747-2757
5. Boccardo F, Rubagotti A, Puntoni M et al (2005) Switching to anastrozole versus continued tamoxifen treatment of early breast cancer: preliminary results of the Italian Tamoxifen Anastrozole Trial. J Clin Oncol 23:5138-5147
6. Jakesz R, Jonat W, Gnant M et al (2005) Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial. Lancet 366:455-462
7. Ingle J (2005) Endocrine therapy trials of aromatase inhibitors for breast cancer in the adjuvant and prevention settings. Clin Cancer Res 11:900s-9005s
8. Goss PE (1999) Risk versus benefits in the clinical application of aromatase inhibitors. Endocrine-Related Cancer 6:325-332
9. Gradishar W (2005) Safety considerations of adjuvant therapy in early breast cancer in postmenopausal women. Oncology 69:1-9
10. Morales L, Neven P, Paridaens R (2005) Choosing between an aromatase inhibitor and tamoxifen in the adjuvant setting. Curr Opin Oncol 17:559-565
11. Geisler J, Lonning PE (2006) Aromatase inhibitors as adjuvant treatment of breast cancer. Crit Rev Oncol Hematol 57(1):53-61
12. Brufsky A (2006) Management of cancer-treatment-induced bone loss in postmenopausal women undergoing adjuvant breast cancer therapy: a Z-FAST update. Semin Oncol 33:S13
13. Coombes R, Paridaens R, Jassem C et al (2006) First mature analysis of the Intergroup Exemestane Study. J Clin Oncol ASCO Annual Proceedings 24 (Suppl 18):(Abstr LBA527)
14. Donnellan P, Douglas S, Cameron D, Leonard R (2001) Aromatase inhibitors and arthralgia. J Clin Oncol 19:2767
15. Morales L, Neven P, Timmerman D et al (2004) Acute effects of tamoxifen and third generation aromatase inhibitors on menopausal symptoms of breast cancer patients. Anti-Cancer Drugs 15:753-760
16. Felson D, Cummings S (2005) Aromatase inhibitors and the syndrome of arthralgias with estrogen deprivation. Arthritis Rheumatism 52:2594-2598
17. The Arimidex, Tamoxifen, Alone or in Combination (ATAC) Trialists' Group (2006) Comprehensive side-effect profile of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: long-term safety analysis of the ATAC trial. Lancet Oncol 7(8):633-643